Columnists

Columns

Rod Liddle

The true cause of the public’s anger

What Keir Starmer should have said, but didn’t, was that he had indeed drunk some beer in a frowsy Labour party constituency office, but that he had not remotely enjoyed it. This would have had the advantage of being true, for a start: even through the blurred window you can see the Labour leader’s face

‘Operation Red Meat’ won’t beef up the government

Are you ready for ‘Operation Red Meat’? If not, then you should brace yourself. For it looks set to be one of the most fearsome operations of modern political times, liable to make Conservative voters quiver with excitement and feel almost too stimulated. Alert readers will have noticed that Boris Johnson did not have the

Good things can come from guilt

I do not know anyone in the Sackler family. I wouldn’t even have heard of them were it not for recent reports of their return to the large-scale philanthropy with which their name was once associated. These reports have led to criticism of institutions that accepted Sackler charity: the well-worn argument being that the family’s

Joe Biden’s Civil War re-enactment

We can’t blame American progressives for yearning to relive the civil rights movement. Those were heady days. Opposition to segregation — real ‘structural racism’ — placed you conspicuously on the proverbial right side of history. Joining the cause was like shooting up moral heroin. So maybe it’s predictable that when talking up his two voting

The Spectator's Notes

The curious case of Barry Gardiner

In May 2020, in the wake of the Barnard Castle story, Emily Maitlis delivered her famous Newsnight address to the nation: ‘Dominic Cummings broke the rules. The country can see that, and it’s shocked the government cannot.’ The public felt ‘fury, contempt and anguish’ at what had happened. The Prime Minister was showing ‘blind loyalty’

Any other business

The TV licence is a dead duck

‘Tell me we’re winning the media battle!’ I imagine Unilever boss Alan Jope barking at his team on Tuesday, following the revelation on Sunday of his rejected £50 billion bid for GlaxoSmithKline’s consumer healthcare arm. ‘Yes, sir,’ replies the flustered PR, ‘Very much so… except for top investor Richard Buxton of Jupiter telling the FT: